A Study Conducted Over 3 Periods to Look at the Drug in the Body

Clinical trial NCT01225939 · COMPLETED

Trial details

NCT number: NCT01225939
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-11-01
Primary completion: 2010-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.